World

AstraZeneca to Test New Cancer Medicine in Covid-19 Battle

Drug may help reduce need for Covid patients to be ventilated
Pharmaceutical giant planning to test drug in U.S., Europe

Do We Already Have the Cure For COVID-19?

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Marthe Fourcade and Suzi Ring

April 14, 2020 at 6:48 AM UTC

Updated on

April 14, 2020 at 3:13 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

AstraZeneca Plc will start testing one of its new cancer medicines to see whether it can quell the excessive immune response Covid-19 triggers in some patients.